155 related articles for article (PubMed ID: 37341499)
21. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
Pham K; Maxwell MJ; Sweeney H; Alt J; Rais R; Eberhart CG; Slusher BS; Raabe EH
J Neuropathol Exp Neurol; 2021 Mar; 80(4):336-344. PubMed ID: 33712838
[TBL] [Abstract][Full Text] [Related]
22. Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
Zhang GQ; Xi C; Ju NT; Shen CT; Qiu ZL; Song HJ; Luo QY
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38386265
[TBL] [Abstract][Full Text] [Related]
23. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
Shelton LM; Huysentruyt LC; Seyfried TN
Int J Cancer; 2010 Nov; 127(10):2478-85. PubMed ID: 20473919
[TBL] [Abstract][Full Text] [Related]
24. Modulating glutamine metabolism to control viral immuno-inflammatory lesions.
Sumbria D; Berber E; Miller L; Rouse BT
Cell Immunol; 2021 Dec; 370():104450. PubMed ID: 34678554
[TBL] [Abstract][Full Text] [Related]
25. Sirpiglenastat (DRP-104) Induces Antitumor Efficacy through Direct, Broad Antagonism of Glutamine Metabolism and Stimulation of the Innate and Adaptive Immune Systems.
Yokoyama Y; Estok TM; Wild R
Mol Cancer Ther; 2022 Oct; 21(10):1561-1572. PubMed ID: 35930753
[TBL] [Abstract][Full Text] [Related]
26. Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro.
Greene RM; Kochhar DM
J Embryol Exp Morphol; 1975 Apr; 33(2):355-70. PubMed ID: 1176851
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
Shapiro RA; Clark VM; Curthoys NP
J Biol Chem; 1979 Apr; 254(8):2835-8. PubMed ID: 429321
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of glutamine in erythrocytes infected with the human malaria parasite: Plasmodium falciparum.
Vilmont M; Azoulay M; Frappier F
Ann Parasitol Hum Comp; 1990; 65(4):162-6. PubMed ID: 1982204
[TBL] [Abstract][Full Text] [Related]
29. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory Effect of a Glutamine Antagonist on Proliferation and Migration of VSMCs via Simultaneous Attenuation of Glycolysis and Oxidative Phosphorylation.
Park HY; Kim MJ; Lee S; Jin J; Lee S; Kim JG; Choi YK; Park KG
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070527
[TBL] [Abstract][Full Text] [Related]
31. Poliovirus and vesicular stomatitis virus replication in the presence of 6-diazo-5-oxo-L-norleucine or 2-deoxy-D-glucose.
Goldstein G; Guskey LE
J Med Virol; 1984; 14(2):159-67. PubMed ID: 6208320
[TBL] [Abstract][Full Text] [Related]
32. Transport and membrane binding of the glutamine analogue 6-diazo-5-oxo-L-norleucine (DON) in Xenopus laevis oocytes.
Taylor PM; Mackenzie B; Hundal HS; Robertson E; Rennie MJ
J Membr Biol; 1992 Jun; 128(3):181-91. PubMed ID: 1501246
[TBL] [Abstract][Full Text] [Related]
33. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.
Edwards DN; Ngwa VM; Raybuck AL; Wang S; Hwang Y; Kim LC; Cho SH; Paik Y; Wang Q; Zhang S; Manning HC; Rathmell JC; Cook RS; Boothby MR; Chen J
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33320840
[TBL] [Abstract][Full Text] [Related]
34. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Huber KR; Rosenfeld H; Roberts J
Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
[TBL] [Abstract][Full Text] [Related]
35. Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry.
Alt J; Potter MC; Rojas C; Slusher BS
Anal Biochem; 2015 Apr; 474():28-34. PubMed ID: 25584882
[TBL] [Abstract][Full Text] [Related]
36. Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor.
Gao RD; Hin N; Prchalová E; Pal A; Lam J; Rais R; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2021 Oct; 50():128321. PubMed ID: 34400301
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism.
Murphy C; Newsholme P
Clin Sci (Lond); 1999 Jan; 96(1):89-97. PubMed ID: 9857111
[TBL] [Abstract][Full Text] [Related]
38. Targeting age-specific changes in CD4
Nian Y; Iske J; Maenosono R; Minami K; Heinbokel T; Quante M; Liu Y; Azuma H; Yang J; Abdi R; Zhou H; Elkhal A; Tullius SG
Aging Cell; 2021 Feb; 20(2):e13299. PubMed ID: 33497523
[TBL] [Abstract][Full Text] [Related]
39. Effects of diazo-oxo-norleucine on cell kinetics and odontoblast differentiation in cultured embryonic mouse molars.
Olive M; Ruch JV
Arch Oral Biol; 1982; 27(6):505-11. PubMed ID: 6956264
[TBL] [Abstract][Full Text] [Related]
40. Glutamine in the mechanism of ammonia-induced astrocyte swelling.
Jayakumar AR; Rao KV; Murthy ChR; Norenberg MD
Neurochem Int; 2006; 48(6-7):623-8. PubMed ID: 16517020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]